Púrpura trombótica trombocitopénica

Moschcowitz, 1925, An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries, Arch Intern Med, 36, 89, 10.1001/archinte.1925.00120130092009

Fujikawa, 2001, Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family, Blood, 98, 1662, 10.1182/blood.V98.6.1662

Terrell, 2005, The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: All patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency, J Thromb Haemost, 3, 1432, 10.1111/j.1538-7836.2005.01436.x

Ridolfi, 1981, Thrombotic thrombocytopenic purpura: Report of 25 cases and review of the literature, Medicine (Baltimore), 60, 413, 10.1097/00005792-198111000-00003

Murria, 2006, Thrombotic thrombocytopenic purpura: Aetiology, pathophysiology and treatment, Blood Rev, 20, 51, 10.1016/j.blre.2005.02.001

Moake, 2007, Journey in reverse: TTP from bedside to blood bank to bench, J Clin Aph, 22, 37, 10.1002/jca.20110

Veyradier, 2004, Ten candidate ADAMTS13 mutations in six French families with congenital thrombocytopenic purpura (Upshaw-Schulman syndrome), J Thromb Haemost, 2, 424, 10.1111/j.1538-7933.2004.00623.x

Amorosi, 1966, Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature, Medicine (Baltimore), 45, 139, 10.1097/00005792-196603000-00003

Rock, 1998, Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group, Br J Haematol, 103, 1031, 10.1046/j.1365-2141.1998.01080.x

Cuttner, 1980, Thrombotic thrombocytopenic purpura: A ten year experience, Blood, 56, 302, 10.1182/blood.V56.2.302.302

Olsen, 1973, Thrombotic thrombocytopenic purpura as a cause of pancreatitis: Report of a case and review of the literature, Dig Dis, 18, 238, 10.1007/BF01071978

Bell, 1990, Thrombotic thrombocytopenic purpura causing sudden unexpected death – a series of 8 patients, Am J Forensic Sci, 35, 601

Ridolfi, 1979, The heart and cardiac conduction system in thrombotic thrombocytopenic purpura: A clinicopathologic study of 17 autopsied patients, Ann Intern Med, 91, 357, 10.7326/0003-4819-91-3-357

Shumak, 1995, Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura, Ann Intern Med, 122, 569, 10.7326/0003-4819-122-8-199504150-00002

Sadler, 2004, Recent advances in thrombotic thrombocytopenic purpura, Hematology, 407, 10.1182/asheducation-2004.1.407

Bennett, 1999, Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention, Arch Intern Med, 159, 2524, 10.1001/archinte.159.21.2524

Gottschall, 1994, Quinine-induced immune thrombocytopenia with hemolytic uremia syndrome: Clinical and serological findings in nine patients and review of literature, Am J Hematol, 47, 283, 10.1002/ajh.2830470407

Zarifian, 1999, Cyclosporine-associated thrombotic microangiopathy in renal allografts, Kidney Int, 55, 2457, 10.1046/j.1523-1755.1999.00492.x

Leaf, 1988, Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection, Ann Intern Med, 109, 194, 10.7326/0003-4819-109-3-194

Gordon, 1999, Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura hemolytic uremic syndrome in the cancer patient, Semin Thromb Hemost, 25, 217, 10.1055/s-2007-994923

Dong, 2002, ADAMTS13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions, Blood, 100, 4033, 10.1182/blood-2002-05-1401

Donadelli, 2006, Size regulation of von Willebrand factor–mediated platelet thrombi by ADAMTS13 in flowing blood, Blood, 107, 1943, 10.1182/blood-2005-07-2972

Rieger, 2005, ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases, Blood, 106, 1262, 10.1182/blood-2004-11-4490

Bianchi, 2002, Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: A severely deficient activity is specific for thrombotic thrombocytopenic purpura, Blood, 100, 710, 10.1182/blood-2002-02-0344

Kwaan, 2005, Thrombotic thrombocytopenic purpura, Semin Thromb Hemost, 31, 611, 10.1055/s-2005-925466

Banno, 2006, Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura, Blood, 107, 3161, 10.1182/blood-2005-07-2765

Tsai, 2007, Thrombotic thrombocytopenic purpura: A thrombotic disorder caused by ADAMTS13 deficiency, Hematol Oncol Clin North Am, 21, 609, 10.1016/j.hoc.2007.06.003

Mannucci, 2007, TTP and ADAMTS13: When is testing appropriate?, Hematology, 121, 10.1182/asheducation-2007.1.121

Kato, 2006, Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS-13 activity, Transfusion, 46, 1444, 10.1111/j.1537-2995.2006.00914.x

Ferrari, 2007, Blood, 109, 2815, 10.1182/blood-2006-02-006064

Peyvandi, 2008, ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission, Haematology, 93, 232, 10.3324/haematol.11739

Nolasco, 2005, Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers, Blood, 106, 4199, 10.1182/blood-2005-05-2111

Rock, 2009, Mechanism of microthrombosis in HUS, Kidney Int, 75, S11, 10.1038/ki.2008.611

Kavanagh, 2006, Atypical haemolytic uraemic syndrome, Br Med Bull, 77, 5, 10.1093/bmb/ldl004

Coppo, 2004, Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement, Medicine (Baltimore), 83, 233, 10.1097/01.md.0000133622.03370.07

Tostivint, 2002, Adult haemolytic and uraemic syndrome: Causes and prognostic factors in the last decade, Nephrol Dial Transplant, 17, 1228, 10.1093/ndt/17.7.1228

Byrnes, 1977, Treatment of thrombotic thrombocytopenic purpura with plasma, N Engl J Med, 297, 1386, 10.1056/NEJM197712222972507

Szczepiorkowski, 2007, Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis, J Clin Apheresis, 22, 106, 10.1002/jca.20129

Michael M, Elliott EJ, Ridley GF, Hodson EM, Craig JC. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev. 2009;21:CD003595

Raife, 2006, The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: Reconsideration of treatment with cryopoor plasma, Transfusion, 46, 74, 10.1111/j.1537-2995.2005.00674.x

Del Río, 2008, Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: A multicentric, prospective cohort study, Br J Haematol, 143, 39, 10.1111/j.1365-2141.2008.07292.x

Cataland, 2006, An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura, Br J Haematol, 132, 146

Rosove, 1982, Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura, Ann Int Med, 96, 27, 10.7326/0003-4819-96-1-27

Kappers-Klunne, 2005, Splenectomy for the treatment of thrombotic thrombocytopenic purpura, Br J Haematol, 130, 768, 10.1111/j.1365-2141.2005.05681.x

Ziman, 2005, Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: One institution's experience and review of the literature, Transfusion, 45, 41, 10.1111/j.1537-2995.2005.03146.x

Hand, 1998, Successful use of cyclosporin A in the treatment of refractory thrombotic thrombocytopenic purpura, Br J Haematol, 100, 597, 10.1046/j.1365-2141.1998.00602.x

Fakhouri, 2005, Efficiency of curative and prophylactic treatment with rituximab in ADAMTS 13 deficient thrombotic thrombocytopenic purpura: A study of 11 cases, Blood, 106, 1932, 10.1182/blood-2005-03-0848

Scully, 2007, Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13, Br J Haematol, 136, 451, 10.1111/j.1365-2141.2006.06448.x

Ling, 2009, Sustained response in patients with thrombotic thrombocytopenic purpura: A report of 13 cases and review of the literature, Am J Hematol, 84, 418, 10.1002/ajh.21439

Foley, 2009, A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura, Kidney Int, 75, S55, 10.1038/ki.2008.629